Correction to: Beneficial effects of the nutritional supplements on the development of diabetic retinopathy (Nutrition & Metabolism, (2014), 11, 1, (8), 10.1186/1743-7075-11-8);Beneficial effects of the nutritional supplements on the development of diabetic retinopathy

Nutrition and Metabolism

Volumn 11, Issue 1, 2014, Pages

  Kowluru, Renu A ^a   Zhong, Qing ^a   Santos, Julia M ^a   Thandampallayam, Mangayarkarasi ^a   Putt, Doug ^a   Gierhart, Dennis L ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b LLC   (United States)

Author keywords

Carotenoids; Diabetic retinopathy; Macular pigment; Mitochondria; Nutritional supplements; Zeaxanthin

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BENFOTIAMINE; CAROTENOID; COLECALCIFEROL; DOCOSAHEXAENOIC ACID; FISH OIL; GRAPE SEED EXTRACT; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOCHONDRIAL DNA; OMEGA 3 FATTY ACID; THIOCTIC ACID; UBIDECARENONE; VASCULOTROPIN; XANTHOPHYLL; ZEAXANTHIN; ZINC;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B WAVE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DISEASE SEVERITY; ELECTRORETINOGRAPHY; FOOD INTAKE; HISTOPATHOLOGY; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RESPIRATORY CHAIN; RETINA; RETINA CAPILLARY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; URINE VOLUME;

ANIMALIA; RATTUS;

EID: 84896723232     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/s12986-021-00620-w     Document Type: Erratum

References (49)

1. Mitochondria damage in the pathogenesis of diabetic retinopathy and in the metabolic memory associated with its continued progression. Kowluru RA, Curr Med Chem 2013 20 3226 3233 10.2174/09298673113209990029 23745551
2. Diabetes-induced mitochondrial dysfunction in the retina. Kowluru RA, Abbas SN, Inves Ophthalmol Vis Sci. 2003 44 5327 5334 10.1167/iovs.03-0353
3. Therapeutic potential of anti-oxidants and diabetic retinopathy. Kowluru RA, Kennedy A, Expert Opin Investig Drugs 2001 10 1665 1676 10.1517/13543784.10. 9.1665 11772276
4. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Kowluru RA, Tang J, Kern TS, Diabetes 2001 50 1938 1942 10.2337/diabetes.50.8.1938 11473058
5. Oxidative damage of mitochondrial DNA in diabetes, and its protection by manganese superoxide dismutase. Madsen-Bouterse S, Zhong Q, Mohammad G, Ho YS, Kowluru RA, Free Rad Research. 2010 44 313 321 10.3109/10715760903494168
6. Mitochondria biogenesis and the development of diabetic retinopathy. Santos JM, Tewari S, Goldberg AFX, Kowluru RA, Free Rad Biol Med. 2011 51 1849 1860 10.1016/j.freeradbiomed.2011.08.017 21911054
7. Effects of modified ldl and hdl on retinal pigment epithelial cells: a role in diabetic retinopathy? Du M, Wu M, Fu D, Yang S, Chen J, Wilson K, Lyons TJ, Diabetologia 2013 56 2318 2328 10.1007/s00125-013-2986-x 23842729
8. Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Du Y, Veenstra A, Palczewski K, Kern TS, Proc Natl Acad Sci USA 2013 110 16586 16591 10.1073/pnas.1314575110 24067647
9. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Kowluru RA, Kanwar M, Chan PS, Zhang JP, Arch Ophthalmol 2008 126 1266 1272 10.1001/archopht.126.9.1266 18779489
10. Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Kowluru RA, Odenbach S, Diabetes 2004 53 3233 3238 10.2337/diabetes.53.12.3233 15561955
11. A central role for inflammation in the pathogenesis of diabetic retinopathy. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP, FASEB J 2004 18 1450 1452 15231732
12. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Kern TS, Exp Diabetes Res 2007 2007 95103 18274606
13. Angiogenic pathways in diabetic retinopathy. Aiello LP, N Engl J Med 2005 353 839 841 10.1056/NEJMe058142 16120866
14. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase c in vivo and suppressed by an orally effective beta isoform-selective inhibitor. Aiello LP, Brusell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LEH, King GL, Diabetes 1997 46 1473 1480 10.2337/diab.46.9.1473 9287049
15. Effect of curcumin on retinal oxidative stress and inflammation in diabetes. Kowluru RA, Kanwar M, Nutr Metab (Lond) 2007 4 1 8 10.1186/1743-7075-4-1 17204161
16. Resistance of retinal inflammatory mediators to suppress after re-institution of good glycemic control: Novel mechanism for metabolic memory. Chan PS, Kanwar M, Kowluru RA, J Diabetes Complications 2010 24 55 63 10.1016/j.jdiacomp.2008.10.002 19056300
17. Role of interleukin-1beta in the development of retinopathy in rats: Effect of antioxidants. Kowluru RA, Odenbach S, Invest Ophthalmol Vis Sci 2004 45 4161 4166 10.1167/iovs.04-0633 15505070
18. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Kowluru RA, Koppolu P, Chakrabarti S, Chen S, Free Radic Research. 2003 37 1169 1180 10.1080/10715760310001604189
19. Polyunsaturated very-long-chain c28-c36 fatty acids and retinal physiology. McMahon A, Kedzierski W, Br J Ophthalmol 2010 94 1127 1132 10.1136/bjo.2008.149286 19666930
20. Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases elovl2 and elovl4. Tikhonenko M, Lydic TA, Wang Y, Chen W, Opreanu M, Sochacki A, McSorley KM, Renis RL, Kern T, Jump DB, Reid GE, Busik JV, Diabetes 2009 59 219 227 19875612
21. Impact of dietary carotenoid deprivation on macular pigment and serum concentrations of lutein and zeaxanthin. Loughman J, Nolan JM, Beatty S, Br J Nutr 2012 108 2102 2103 10.1017/S0007114512004461 23098649
22. Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. Lima VC, Rosen RB, Maia M, Prata TS, Dorairaj S, Farah ME, Sallum J, Invest Ophthalmol Vis Sci 2010 51 5840 5845 10.1167/iovs.09-4695 20505210
23. The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. SanGiovanni JP, Neuringer M, Am J Clin Nutr 2012 96 1223S 1233S 10.3945/ajcn.112.038240 23053548
24. Beyond AREDS: Is there a place for anti-oxidant therapy in the prevention/ treatment of eye disease? Kowluru RA, Zhong Q, Invest Ophthalmol Vis Sci 2011 52 8665 8671 10.1167/iovs.10-6768 22065212
25. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The age-related eye disease study 2 (AREDS2) randomized clinical trial. The Age-Related Eye Disease Study 2 (AREDS2) Research Group, JAMA 2013 309 2005 2015 23644932
26. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rat. Kowluru RA, Menon B, Gierhart D, Inves Ophthalmol Vis Sci. 2008 49 1645 1651 10.1167/iovs.07-0764
27. Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Kern TS, Miller CM, Tang J, Du Y, Ball SL, Berti-Matera L, Mol Vis 2010 16 1629 1639 20806092
28. Acute inflammation and loss of retinal architecture and function during experimental bacillus endophthalmitis. Ramadan RT, Ramirez R, Novosad BD, Callegan MC, Curr Eye Res 2006 31 955 965 10.1080/02713680600976925 17114121
29. A compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathy. Santos JM, Tewari S, Kowluru RA, Free Rad Biol Med. 2012 53 1729 1737 10.1016/j.freeradbiomed.2012.08.588 22982046
30. Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes. Kowluru RA, Kowluru A, Kanwar M, Mol Cell Biochem 2007 296 69 76 10.1007/s11010-006-9299-z 16924412
31. Interleukin-1b and mitochondria damage, and the development of diabetic retinopathy. Kowluru RA, Mohammad G, Santos J, Tewari S, Zhong Q, J Ocular Biology, Diseases and Informatics. 2011 4 3 9 10.1007/s12177-011-9074-6
32. Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin. Kern TS, Engerman RL, Diabetes 2001 50 1636 1642 10.2337/diabetes.50.7. 1636 11423486
33. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. Mizutani M, Kern TS, Lorenzi M, J Clin Invest 1996 97 2883 2890 10.1172/JCI118746 8675702
34. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW, J Clin Invest 1998 102 783 791 10.1172/JCI2425 9710447
35. Diabetes-induced impairment in visual function in mice: Contributions of p38 MAPK, RAGE, leukocytes, and aldose reductase. Lee CA, Li G, Patel MD, Petrash JM, Benetz BA, Veenstra A, Amengual J, Von Lintig J, Burant C, Tang J, Kern TS, Invest Ophthalmol Vis Sci 2013 Aug 6, Epub ahead of print
36. Susceptibility of streptozotocin-induced diabetic rat retinal function and ocular blood flow to acute intraocular pressure challenge. Wong VH, Vingrys AJ, Jobling AI, Bui BV, Invest Ophthalmol Vis Sci 2013 54 2133 2141 10.1167/iovs.13-11595 23439594
37. Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Lecleire-Collet A, Audo I, Aout M, Girmens JF, Sofroni R, Erginay A, Le Gargasson JF, Mohand-Said S, Meas T, Guillausseau PJ, Vicaut E, Paques M, Massin P, Invest Ophthalmol Vis Sci 2011 52 2861 2867 10.1167/iovs.10-5960 21282578
38. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Ng JS, Bearse MA Jr, Schneck ME, Barez S, Adams AJ, Invest Ophthalmol Vis Sci 2008 49 1622 1628 10.1167/iovs.07-1157 18385083
39. Macular pigment: A review of current knowledge. Whitehead AJ, Mares JA, Danis RP, Arch Ophthalmol 2006 124 1038 1045 10.1001/archopht.124.7.1038 16832030
40. Biologic activity of carotenoids related to distinct membrane physicochemical interactions. McNulty H, Jacob RF, Mason RP, Am J Cardiol 2008 101 20D 29D 18474269
41. Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes. Tang L, Zhang Y, Jiang Y, Willard L, Ortiz E, Wark L, Medeiros D, Lin D, Exp Biol Med (Maywood) 2011 236 1051 1063 10.1258/ebm.2011.010400 21750018
42. effect of extract of lycium barbarum l. On adult human retinal nerve cells. Shen ZJ, Wang JJ, Li GL, Zhonghua Yan Ke Za Zhi 2012 48 824 828 23141579
43. Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy. Santos JM, Kowluru RA, Invest Ophthalmol Vis Sci 2011 52 8791 8798 10.1167/iovs.11-8203 22003111
44. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, Frank RN, Stevens MJ, Diabetologia 2001 44 1102 1110 10.1007/s001250100631 11596663
45. Activation of nuclear factor-kappab induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M, Diabetes 2002 51 2241 2248 10.2337/diabetes.51.7.2241 12086956
46. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Vincent JA, Mohr S, Diabetes 2007 56 224 230 10.2337/db06-0427 17192486
47. Alterations to the blood-retinal barrier in diabetes: Cytokines and reactive oxygen species. Frey T, Antonetti DA, Antioxid Redox Signal 2011 15 1271 1284 10.1089/ars.2011.3906 21294655
48. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the atherosclerosis risk in communities study. Millen AE, Klein R, Folsom AR, Stevens J, Palta M, Mares JA, Am J Clin Nutr 2004 79 865 873 15113727
49. Oxidative stress in preretinopathic diabetes subjects and antioxidants. Nebbioso M, Federici M, Rusciano D, Evangelista M, Pescosolido N, Diabetes Technol Ther 2012 14 257 263 10.1089/dia.2011.0172 22044044